Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: An update on the risk factors, surveillance regimens and treatments

BJU International

Volumn 100, Issue 1, 2007, Pages 11-16

  Sanderson, Kristin M ^a   Rouprêt, Morgan ^b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bladder cancer; Carcinoma; Recurrence; Surveillance; Transitional cell; Urinary tract cancer

Indexed keywords

ADVANCED CANCER; ANASTOMOSIS; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL FEATURE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; FLANK PAIN; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATURIA; HIGH RISK PATIENT; HUMAN; LAPAROSCOPIC SURGERY; MINIMALLY INVASIVE SURGERY; NEPHROURETERECTOMY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PYELONEPHRITIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; URETER CARCINOMA; URETEROILEAL ANASTOMOSIS; URETEROSCOPY; URETHRA CARCINOMA; URINE CYTOLOGY; UROGENITAL TRACT CANCER; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 34249942728     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06841.x     Document Type: Short Survey

References (22)

1. Slaton JW, Swanson DA, Grossman HB, Dinney CP. A stage specific approach to tumour surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1999 162 : 710 4
2. Solsona E, Iborra I, Rubio J, Casanova J, Dumont R, Monros JL. Late oncological occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 2003 43 : 489 94
3. Balaji KC, McGuire M, Grotas J, Grimaldi G, Russo P. Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol 1999 162 : 1603 6
4. Kenworthy P, Tanguay S, Dinney CP. The risk of upper tract recurrence following cystectomy in patients with transitional cell carcinoma involving the distal ureter. J Urol 1996 155 : 501 3
5. Sved PD, Gomez P, Nieder AM, Manoharan M, Kim SS, Soloway MS. Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors. BJU Int 2004 94 : 785 9
6. Huguet-Perez J, Palou J, Millan-Rodriguez F, Salvador-Bayarri J, Villavicencio-Mavrich H, Vicente-Rodriguez J. Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur Urol 2001 40 : 318 23
7. Akkad T, Gozzi C, Deibl M et al. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. J Urol 2006 175 : 1268 71
8. Sanderson KM, Stein JP, Cai J et al. Upper tract recurrence following radical cystectomy for transitional cell carcinoma. an analysis of 1069 patients with 10-year follow-up. J Urol 2007 in press
9. Yossepowitch O, Dalbagni G, Golijanin D et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 2003 169 : 177 81
10. Solsona E, Iborra I, Ricos JV, Dumont R, Casanova JL, Calabuig C. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management. Urology 1997 49 : 347 52
11. Rouprêt M, Hupertan V, Traxer O et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 2006 67 : 1181 7
12. van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 2005 47 : 736 48
13. Chen GL, El-Gabry EA, Bagley DH. Surveillance of upper urinary tract transitional cell carcinoma: the role of ureteroscopy, retrograde pyelography, cytology and urinalysis. J Urol 2000 164 : 1901 4
14. Malkowicz SB, Skinner DG. Development of upper tract carcinoma after cystectomy for bladder carcinoma. Urology 1990 36 : 20 2
15. Scolieri MJ, Paik ML, Brown SL, Resnick MI. Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma. Urology 2000 56 : 930 4
16. Bretheau D, Lechevallier E, Uzan E, Rampal M, Coulange C. [Value of radiologic examinations in the diagnosis and staging of upper urinary tract tumours]. Prog Urol 1994 4 : 966 73
17. Schoenberg MP, Carter HB, Epstein JI. Ureteral frozen section analysis during cystectomy: a reassessment. J Urol 1996 155 : 1218 20
18. Guarnizo E, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr, Sosa RE. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathological considerations using a multi-biopsy approach. J Urol 2000 163 : 52 5
19. Lee BR, Jabbour ME, Marshall FF, Smith AD, Jarrett TW. 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes. J Endourol 1999 13 : 289 94
20. Raj GV, Tal R, Vickers A et al. Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer 2006 107 : 2167 72
21. Goel MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumours: long-term followup. J Urol 2003 169 : 925 30
22. Mullerad M, Russo P, Golijanin D et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. J Urol 2004 172 : 2177 81